Tag Archives: MONALEESA-7 trial

Novartis: positive topline results from the global MONALEESA-7 trial

MONALEESA-7 met primary endpoint of progression-free survival, demonstrating superior efficacy of Kisqali combination therapy vs. endocrine treatment alone in first-line treatment of premenopausal women with HR+/HER2- advanced breast cancer[1]  Kisqali is the first CDK4/6 inhibitor to be studied in a Phase … Read the full press release